KR100360568B1 - 16-membered ring macrolide derivative and method for manufacturing the same - Google Patents

16-membered ring macrolide derivative and method for manufacturing the same Download PDF

Info

Publication number
KR100360568B1
KR100360568B1 KR1019940016581A KR19940016581A KR100360568B1 KR 100360568 B1 KR100360568 B1 KR 100360568B1 KR 1019940016581 A KR1019940016581 A KR 1019940016581A KR 19940016581 A KR19940016581 A KR 19940016581A KR 100360568 B1 KR100360568 B1 KR 100360568B1
Authority
KR
South Korea
Prior art keywords
membered ring
manufacturing
same
macrolide derivative
ring macrolide
Prior art date
Application number
KR1019940016581A
Other languages
English (en)
Inventor
Keiichi Ajito
Osamu Hara
Kenichi Kurihara
Nobue Kikuchi
Minako Araake
Akira Shimizu
Tsuneo Okonogi
Shigeharu Inouye
Seiji Shibahara
Original Assignee
Meiji Seika Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP16941893A external-priority patent/JP3023041B2/ja
Priority claimed from JP5300686A external-priority patent/JPH07149788A/ja
Priority claimed from JP6105096A external-priority patent/JPH07309889A/ja
Priority claimed from JP6126654A external-priority patent/JPH07330791A/ja
Priority claimed from JP6145125A external-priority patent/JPH0812696A/ja
Application filed by Meiji Seika Ltd filed Critical Meiji Seika Ltd
Application granted granted Critical
Publication of KR100360568B1 publication Critical patent/KR100360568B1/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
KR1019940016581A 1993-07-08 1994-07-08 16-membered ring macrolide derivative and method for manufacturing the same KR100360568B1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP16941893A JP3023041B2 (ja) 1993-07-08 1993-07-08 新規１６員環マクロリド誘導体
JP5300686A JPH07149788A (ja) 1993-11-30 1993-11-30 新規１６員環マクロリド誘導体及びそれらの効率的製造法
JP6105096A JPH07309889A (ja) 1994-05-19 1994-05-19 新規１６員環マクロリド誘導体及びそれらの新規製造法
JP6126654A JPH07330791A (ja) 1994-06-08 1994-06-08 新規１６員環マクロリド誘導体及びそれらの新規包括的製造法
JP6145125A JPH0812696A (ja) 1994-06-27 1994-06-27 新規１６員環マクロリド誘導体及びそれらの効率的製造法

Publications (1)

Publication Number Publication Date
KR100360568B1 true KR100360568B1 (en) 2003-03-12

Family

ID=27526205

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019940016581A KR100360568B1 (en) 1993-07-08 1994-07-08 16-membered ring macrolide derivative and method for manufacturing the same

Country Status (8)

Country Link
US (1) US5602106A (ko)
EP (1) EP0633266B1 (ko)
KR (1) KR100360568B1 (ko)
CN (2) CN1046534C (ko)
AT (1) ATE165604T1 (ko)
CA (1) CA2127578A1 (ko)
DE (1) DE69409874T2 (ko)
ES (1) ES2115816T3 (ko)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1191031A4 (en) * 1999-06-01 2002-09-18 Meiji Seika Kaisha LEUCOMYCIN DERIVATIVES MODIFIED IN POSITION 3
EP2029147B1 (en) 2006-06-12 2010-05-19 Ramot at Tel-Aviv University Ltd. Methods for treating cancer
CN102344946B (zh) * 2010-08-02 2014-06-25 中牧实业股份有限公司 一种生物转化合成普拉特霉素a1的方法
EP2671887A4 (en) * 2011-01-31 2014-06-25 Meiji Seika Pharma Co Ltd NEW MACROLIDE DERIVATIVE
KR20150098675A (ko) 2012-12-24 2015-08-28 라모트 앳 텔-아비브 유니버시티 리미티드 넌센스 돌연변이로부터 생긴 유전적 질환을 치료하기 위한 물질 및 이를 확인하는 방법
AU2018247555B2 (en) * 2017-04-06 2024-04-18 Shenyang Fuyang Pharmaceutical Technology Co., Ltd. Use of carrimycin and pharmaceutically acceptable salt thereof for manufacture of medicament for treatment and/or prevention of tumors
ES2912734T3 (es) * 2017-07-04 2022-05-27 Shenyang Fuyang Pharmaceutical Tech Co Ltd Uso de isovaleril espiramicina I o III en la preparación de fármaco para tratar y/o prevenir el tumor y fármaco

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2638458A1 (fr) * 1988-10-27 1990-05-04 Adir Nouveaux derives de la tylosine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
JP3063943B2 (ja) * 1992-02-26 2000-07-12 明治製菓株式会社 血漿中において抗菌活性の持続する新規１６員環マクロリド誘導体及びその合成中間体とそれらの製造法
DE69324434T2 (de) * 1992-10-29 1999-12-23 Meiji Seika Kaisha Ltd., Tokio/Tokyo 16-Gliederige Makrolid-Derivate und Verfahren zu deren Herstellung

Also Published As

Publication number Publication date
EP0633266B1 (en) 1998-04-29
CN1046534C (zh) 1999-11-17
CN1219539A (zh) 1999-06-16
US5602106A (en) 1997-02-11
DE69409874D1 (de) 1998-06-04
DE69409874T2 (de) 1999-01-21
EP0633266A1 (en) 1995-01-11
CN1093134C (zh) 2002-10-23
CA2127578A1 (en) 1995-01-09
CN1106818A (zh) 1995-08-16
ES2115816T3 (es) 1998-07-01
ATE165604T1 (de) 1998-05-15

Similar Documents

Publication Publication Date Title
DE69127457D1 (en) 6-0-methylerythromycin a-derivat
AU4022393A (en) 5-O-desosaminylerythronolide a derivative
CA2009741A1 (en) Selective antibacterial agent
BG103673A (en) 3'-n-oxide, 3'-n-dimethylamine, 9-oxime derivatives of erythromycin a
ES8704943A1 (es) Un procedimiento para la fabricacion de derivados de cefalosporina.
IL123551A0 (en) Tricyclic erythromycin derivatives
AU4761693A (en) Benzopyran and benzoxazine derivatives
KR100360568B1 (en) 16-membered ring macrolide derivative and method for manufacturing the same
MD1788F2 (en) Erythromycin A 9-O-oximes derivatives, pharmaceutical composition on base thereof and method of treatment of infectious diseases
AU6475600A (en) Antibiotic caprazamycins and process for producing the same
HRP940251B1 (en) Process for the preparation of azithromycin dihydrochloride
EP0670317A4 (ko)
CA2146322A1 (en) Oleaginous compositions
AU548292B2 (en) 3-3-demethyl derivatives of istamycin b series compounds
ZA91570B (en) A novel antibiotic,deoxymulundocandin,a process for its production and its use as medicament
HU9503388D0 (en) Anxiolytic agent
ZA943426B (en) Synthetic aglucodalbaheptide antibiotics
CS106784A2 (en) Zpusob vyroby 19 epi dianemycinu
EP0657412A4 (ko)
MX9605773A (es) Compuestos de cefalosporina y procesos para la preparacion de los mismos.
CA2122705A1 (en) Optically Active 1-Phenylpyrrolidone Derivative, Intermediate for Producing the Same, and Process for Producing Both
MX9701853A (es) Antibiotico especifico de legionella, micro-organismo que produce el antibiotico y proceso para producir el mismo.
NO951309L (no) Forbindelser for bruk som additiver i oljeholdige sammensetninger

Legal Events

Date Code Title Description
A201 Request for examination
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
LAPS Lapse due to unpaid annual fee